The Antidiabetic Effect of Mesenchymal Stem Cells Is Unrelated to Their Transdifferentiation Potential But to Their Capability to Restore Th1/Th2 Balance and to Modify the Pancreatic Microenvironment

Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases

(2011) Eyal Ben-Ami et al.   AUTOIMMUNITY REVIEWS

Immunological Applications of Stem Cells in Type 1 Diabetes

(2011) Paolo Fiorina et al.   ENDOCRINE REVIEWS

Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome

(2011) Marcelo Ezquer et al.   JOURNAL OF HEPATOLOGY

The Antidiabetic Effect of MSCs Is Not Impaired by Insulin Prophylaxis and Is Not Improved by a Second Dose of Cells

(2011) Fernando Ezquer et al.   PLoS One

Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa

(2010) Paulette Conget et al.   CYTOTHERAPY

Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes

(2010) M. Jurewicz et al.   DIABETES

Cytokines Interleukin-1  and Tumor Necrosis Factor-  Regulate Different Transcriptional and Alternative Splicing Networks in Primary  -Cells

(2009) F. Ortis et al.   DIABETES

Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes

(2009) L. Vija et al.   DIABETES & METABOLISM

Global estimates of the prevalence of diabetes for 2010 and 2030

(2009) J.E. Shaw et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells

(2009) A. M. Madec et al.   DIABETOLOGIA

Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro

(2009) Qiu-Ping Xie et al.   DIFFERENTIATION

Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes

(2009) P. Fiorina et al.   JOURNAL OF IMMUNOLOGY

Upregulating CD4+CD25+FOXP3+ Regulatory T Cells in Pancreatic Lymph Nodes in Diabetic NOD Mice by Adjuvant Immunotherapy

(2009) Bole Tian et al.   TRANSPLANTATION

Systemic Administration of Multipotent Mesenchymal Stromal Cells Reverts Hyperglycemia and Prevents Nephropathy in Type 1 Diabetic Mice

(2008) Fernando E. Ezquer et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia

(2008) Imene Boumaza et al.   JOURNAL OF AUTOIMMUNITY

Disruption of the homeostatic balance between autoaggressive (CD4+ CD40+ ) and regulatory (CD4+ CD25+ FoxP3+ ) T cells promotes diabetes

(2008) Dan M. Waid et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols